Cite

HARVARD Citation

    Cohen, S. et al. (2020). Fenebrutinib Versus Placebo or Adalimumab in Rheumatoid Arthritis: A Randomized, Double‐Blind, Phase II Trial. Arthritis & rheumatology. 72 (9), pp. 1435-1446. [Online]. 
  
Back to record